SEQENS

📍 Écully, France🗓 Founded 2003👥 1,019 employees💰 Last funded Jun 2016
Pharmaceutical Manufacturing🌐 seqens.com
Website LinkedIn
SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group generates a revenue of 1.4 MM€ and operates 24 manufacturing plants and 10 R&D centers in Europe, North America and Asia. 3,400 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
2003
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
2
Frequently asked questions
Who invested in SEQENS?
SEQENS has 2 investors on record on gritt.io.
When did SEQENS last raise funding?
The most recent investment in SEQENS recorded on gritt.io was in June 2016.
When was SEQENS founded?
SEQENS was founded in 2003.
What industry is SEQENS in?
SEQENS operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is SEQENS based?
SEQENS is headquartered in Écully, France.